SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon reports over 5-fold jump in Q2 consolidated net profit

26 Oct 2018 Evaluate

Biocon has reported results for second quarter ended September 30, 2018.

The company has reported a rise of 75.15% in its net profit at Rs 119.80 crore for the quarter under review as compared to Rs 68.40 crore for the same quarter in the previous year. Total income of the company increased by 17.65% at Rs 765.20 crore for Q2FY19 as compared Rs 650.40 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported over 5-fold jump in its net profit at Rs 354.70 crore for the quarter under review as compared to Rs 68.80 crore for the same quarter in the previous year. Total income of the company increased by 34.92% at Rs 1,375.40 crore for Q2FY19 as compared Rs 1,019.40 crore for the corresponding quarter previous year.

Biocon Share Price

383.30 2.55 (0.67%)
07-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.30
Dr. Reddys Lab 1307.00
Cipla 1361.00
Zydus Lifesciences 940.10
Lupin 2460.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×